Back from ASH 2025, Dr Suchitra Sundaram reports on notable frontline CLL data. Time‑limited pirtobrutinib combined with venetoclax and obinutuzumab produced high rates of undetectable minimal ...
Table 1 Recommended modifications of diagnosis and conventional treatment for children and adolescents with acute lymphoblastic leukemia, based on available resources. The French-American-British ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results